Intersection of social determinants of health with ventricular assist device therapy: An integrative review.

Health equity Social determinants of health Ventricular assist device

Journal

Heart & lung : the journal of critical care
ISSN: 1527-3288
Titre abrégé: Heart Lung
Pays: United States
ID NLM: 0330057

Informations de publication

Date de publication:
06 Apr 2024
Historique:
received: 10 02 2024
revised: 15 03 2024
accepted: 02 04 2024
medline: 8 4 2024
pubmed: 8 4 2024
entrez: 7 4 2024
Statut: aheadofprint

Résumé

Social determinants of health (SDOH) may influence the clinical management of patients with heart failure. Further research is warranted on the relationship between SDOH and Ventricular Assist Device (VAD) therapy for heart failure. The purpose of this integrative review was to synthesize the state of knowledge on the intersection of SDOH with VAD therapy. Guided by Whittemore and Knafl's methodology, this literature search captured three concepts of interest including VAD therapy, SDOH, and their domains of intersection with patient selection, decision-making, treatment outcome, and resource allocation. CINAHL, Embase, PsycINFO, PubMed, and Web of Science were searched in March 2023. Articles were included if they were peer-reviewed publications in English, published between 2006 and 2023, conducted in the United States, and examined VAD therapy in the context of adult patients (age ≥ 18 years). 22 quantitative studies meeting the inclusion criteria informed the conceptualization of SDOH using the Healthy People 2030 framework. Four themes captured how the identified SDOH intersected with different processes relating to VAD therapy: patient decision-making, healthcare access and resource allocation, patient selection, and treatment outcomes. Most studies addressed the intersection of SDOH with healthcare access and treatment outcomes. This review highlights substantial gaps in understanding how SDOH intersect with patient and patient selection for VAD. More research using mixed methods designs is warranted. On an institutional level, addressing bias and discrimination may have mitigated health disparities with treatment outcomes, but further research is needed for implementing system-wide change. Standardized assessment of SDOH is recommended throughout clinical practice from patient selection to outpatient VAD care.

Sections du résumé

BACKGROUND BACKGROUND
Social determinants of health (SDOH) may influence the clinical management of patients with heart failure. Further research is warranted on the relationship between SDOH and Ventricular Assist Device (VAD) therapy for heart failure.
OBJECTIVES OBJECTIVE
The purpose of this integrative review was to synthesize the state of knowledge on the intersection of SDOH with VAD therapy.
METHODS METHODS
Guided by Whittemore and Knafl's methodology, this literature search captured three concepts of interest including VAD therapy, SDOH, and their domains of intersection with patient selection, decision-making, treatment outcome, and resource allocation. CINAHL, Embase, PsycINFO, PubMed, and Web of Science were searched in March 2023. Articles were included if they were peer-reviewed publications in English, published between 2006 and 2023, conducted in the United States, and examined VAD therapy in the context of adult patients (age ≥ 18 years).
RESULTS RESULTS
22 quantitative studies meeting the inclusion criteria informed the conceptualization of SDOH using the Healthy People 2030 framework. Four themes captured how the identified SDOH intersected with different processes relating to VAD therapy: patient decision-making, healthcare access and resource allocation, patient selection, and treatment outcomes. Most studies addressed the intersection of SDOH with healthcare access and treatment outcomes.
CONCLUSION CONCLUSIONS
This review highlights substantial gaps in understanding how SDOH intersect with patient and patient selection for VAD. More research using mixed methods designs is warranted. On an institutional level, addressing bias and discrimination may have mitigated health disparities with treatment outcomes, but further research is needed for implementing system-wide change. Standardized assessment of SDOH is recommended throughout clinical practice from patient selection to outpatient VAD care.

Identifiants

pubmed: 38583277
pii: S0147-9563(24)00056-6
doi: 10.1016/j.hrtlng.2024.04.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-70

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mireille Chehade (M)

Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, United States. Electronic address: mmc10044@nyu.edu.

Komal Patel Murali (KP)

Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, United States.

Victoria Vaughan Dickson (VV)

Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, United States.

Margaret M McCarthy (MM)

Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, United States.

Classifications MeSH